Literature DB >> 22711369

Signaling pathways affecting skeletal health.

Pierre J Marie1.   

Abstract

Skeletal health is dependent on the balance between bone resorption and formation during bone remodeling. Multiple signaling pathways play essential roles in the maintenance of skeletal integrity by positively or negatively regulating bone cells. During the last years, significant advances have been made in our understanding of the essential signaling pathways that regulate bone cell commitment, differentiation and survival. New signaling anabolic pathways triggered by parathyroid hormone, local growth factors, Wnt signaling, and calcium sensing receptor have been identified. Novel signals induced by interactions between bone cells-matrix (integrins), osteoblasts/osteocytes (cadherins, connexins), and osteoblasts/osteoclast (ephrins, Wnt-RhoA, semaphorins) have been discovered. Recent studies revealed the key pathways (MAPK, PI3K/Akt) that critically control bone cells and skeletal mass. This review summarizes the most recent knowledge on the major signaling pathways that control bone cells, and their potential impact on the development of therapeutic strategies to improve human bone health.

Entities:  

Mesh:

Year:  2012        PMID: 22711369     DOI: 10.1007/s11914-012-0109-0

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  100 in total

1.  Selective signaling by Akt1 controls osteoblast differentiation and osteoblast-mediated osteoclast development.

Authors:  Aditi Mukherjee; Peter Rotwein
Journal:  Mol Cell Biol       Date:  2011-11-07       Impact factor: 4.272

2.  Eph and ephrin interactions in bone.

Authors:  Koichi Matsuo
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

3.  Osteoblasts play key roles in the mechanisms of action of strontium ranelate.

Authors:  T C Brennan; M S Rybchyn; W Green; S Atwa; A D Conigrave; R S Mason
Journal:  Br J Pharmacol       Date:  2009-06-25       Impact factor: 8.739

4.  N-cadherin adherens junctions mediate osteogenesis through PI3K signaling.

Authors:  Anyonya R Guntur; Clifford J Rosen; Michael C Naski
Journal:  Bone       Date:  2011-09-16       Impact factor: 4.398

5.  The loss of Cbl-phosphatidylinositol 3-kinase interaction perturbs RANKL-mediated signaling, inhibiting bone resorption and promoting osteoclast survival.

Authors:  Naga Suresh Adapala; Mary F Barbe; Wallace Y Langdon; Mary C Nakamura; Alexander Y Tsygankov; Archana Sanjay
Journal:  J Biol Chem       Date:  2010-09-17       Impact factor: 5.157

6.  The Casitas B lineage lymphoma (Cbl) mutant G306E enhances osteogenic differentiation in human mesenchymal stromal cells in part by decreased Cbl-mediated platelet-derived growth factor receptor alpha and fibroblast growth factor receptor 2 ubiquitination.

Authors:  Nicolas Sévère; Hichem Miraoui; Pierre J Marie
Journal:  J Biol Chem       Date:  2011-05-19       Impact factor: 5.157

7.  Decreased oxidative stress and greater bone anabolism in the aged, when compared to the young, murine skeleton with parathyroid hormone administration.

Authors:  Robert L Jilka; Maria Almeida; Elena Ambrogini; Li Han; Paula K Roberson; Robert S Weinstein; Starros C Manolagas
Journal:  Aging Cell       Date:  2010-10       Impact factor: 9.304

8.  N-cadherin interacts with axin and LRP5 to negatively regulate Wnt/beta-catenin signaling, osteoblast function, and bone formation.

Authors:  Eric Haÿ; Emmanuel Laplantine; Valérie Geoffroy; Monique Frain; Thomas Kohler; Ralph Müller; Pierre J Marie
Journal:  Mol Cell Biol       Date:  2008-12-15       Impact factor: 4.272

9.  Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis.

Authors:  Xiaodong Li; Michael S Ominsky; Kelly S Warmington; Sean Morony; Jianhua Gong; Jin Cao; Yongming Gao; Victoria Shalhoub; Barbara Tipton; Raj Haldankar; Qing Chen; Aaron Winters; Tom Boone; Zhaopo Geng; Qing-Tian Niu; Hua Zhu Ke; Paul J Kostenuik; W Scott Simonet; David L Lacey; Chris Paszty
Journal:  J Bone Miner Res       Date:  2009-04       Impact factor: 6.741

10.  Lrp5 functions in bone to regulate bone mass.

Authors:  Yajun Cui; Paul J Niziolek; Bryan T MacDonald; Cassandra R Zylstra; Natalia Alenina; Daniel R Robinson; Zhendong Zhong; Susann Matthes; Christina M Jacobsen; Ronald A Conlon; Robert Brommage; Qingyun Liu; Faika Mseeh; David R Powell; Qi M Yang; Brian Zambrowicz; Han Gerrits; Jan A Gossen; Xi He; Michael Bader; Bart O Williams; Matthew L Warman; Alexander G Robling
Journal:  Nat Med       Date:  2011-05-22       Impact factor: 53.440

View more
  38 in total

Review 1.  Cadherin-mediated cell-cell adhesion and signaling in the skeleton.

Authors:  Pierre J Marie; Eric Haÿ; Dominique Modrowski; Leila Revollo; Gabriel Mbalaviele; Roberto Civitelli
Journal:  Calcif Tissue Int       Date:  2013-05-09       Impact factor: 4.333

2.  The skeleton and the sympathetic nervous system: it's about time!

Authors:  Katherine J Motyl; Clifford J Rosen
Journal:  J Clin Endocrinol Metab       Date:  2012-11       Impact factor: 5.958

Review 3.  [Regulation of bone metabolism in osteoporosis : novel drugs for osteoporosis in development].

Authors:  F Jakob; F Genest; G Baron; U Stumpf; M Rudert; L Seefried
Journal:  Unfallchirurg       Date:  2015-11       Impact factor: 1.000

4.  Cadherins and Wnt signalling: a functional link controlling bone formation.

Authors:  Pierre J Marie; Eric Haÿ
Journal:  Bonekey Rep       Date:  2013-04-17

Review 5.  The roles of Orai and Stim in bone health and disease.

Authors:  Lisa J Robinson; Harry C Blair; John B Barnett; Jonathan Soboloff
Journal:  Cell Calcium       Date:  2019-06-05       Impact factor: 6.817

6.  Parathyroid hormone receptor mediates the anti-myeloma effect of proteasome inhibitors.

Authors:  Maurizio Zangari; Tamara Berno; Ye Yang; Ming Zeng; Hongwei Xu; Lisa Pappas; Guido Tricot; Archana Kamalakar; Donghoon Yoon; Larry J Suva
Journal:  Bone       Date:  2013-12-31       Impact factor: 4.398

Review 7.  Osteoblast dysfunctions in bone diseases: from cellular and molecular mechanisms to therapeutic strategies.

Authors:  Pierre J Marie
Journal:  Cell Mol Life Sci       Date:  2014-12-09       Impact factor: 9.261

8.  Excessive growth hormone expression in male GH transgenic mice adversely alters bone architecture and mechanical strength.

Authors:  S V Lim; M Marenzana; M Hopkinson; E O List; J J Kopchick; M Pereira; B Javaheri; J P Roux; P Chavassieux; M Korbonits; C Chenu
Journal:  Endocrinology       Date:  2015-02-03       Impact factor: 4.736

9.  Sinomenine induces apoptosis in RAW 264.7 cell-derived osteoclasts in vitro via caspase-3 activation.

Authors:  Long-gang He; Xiang-lian Li; Xiang-zhou Zeng; Heng Duan; Song Wang; Lin-sheng Lei; Xiao-juan Li; Shu-wen Liu
Journal:  Acta Pharmacol Sin       Date:  2013-12-23       Impact factor: 6.150

10.  Inactivation of Lrp5 in osteocytes reduces young's modulus and responsiveness to the mechanical loading.

Authors:  Liming Zhao; Joon W Shim; Todd R Dodge; Alexander G Robling; Hiroki Yokota
Journal:  Bone       Date:  2013-01-26       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.